Hung, Kuan-Yu

Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly

Cheng, H.-T., Huang, J.-W., Chiang, C.-K., Yen, C.-J., Hung, K.-Y., & Wu, K.-D. (2012) · The Journal of Clinical Endocrinology & Metabolism

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 140

Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Peritoneal Dialysis: A Pilot Randomized Controlled Trial

Chen, H.-Y., Chiang, C.-K., Wang, H.-H., Hung, K.-Y., Lee, Y.-J., Peng, Y.-S., Wu, K.-D., & Tsai, T.-J. (2008) · American Journal of Kidney Diseases

Sleep and related disordersDialysis and Renal Disease Management

Cited by 111

Cardiovascular and renal efficacy and safety of sodium-glucose cotransporter-2 inhibitors in patients without diabetes: a systematic review and meta-analysis of randomised placebo-controlled trials

Tsai, W.-C., Hsu, S.-P., Chiu, Y.-L., Yang, J.-Y., Pai, M.-F., Ko, M.-J., Tu, Y.-K., Hung, K.-Y., Chien, K.-L., Peng, Y.-S., et al. (2022) · BMJ Open

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 53

Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: a 15-year cohort study

Wu, H.-Y., Peng, C.-L., Chen, P.-C., Chiang, C.-K., Chang, C.-J., Huang, J.-W., Peng, Y.-S., Tu, Y.-K., Chu, T.-S., Hung, K.-Y., et al. (2017) · PLOS ONE

Chronic Kidney Disease and DiabetesRenin-Angiotensin System Studies

Cited by 33

Comparative efficacy and choice of lipid-lowering drugs for cardiovascular and kidney outcomes in patients with chronic kidney disease: A systematic review and network meta-analysis

Lin, Y.-C., Lai, T.-S., Chen, Y.-T., Chou, Y.-H., Chen, Y.-M., Hung, K.-Y., & Tu, Y.-K. (2025) · Journal of the Formosan Medical Association

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 8